456 |
Rebaudioside D purified from the leaves of Stevia rebaudiana (Bertoni) Bertoni (rebaudioside D) |
Pending |
455 |
Bifidobacterium breve M-16V |
Pending |
454 |
Bifidobacterium breve M-16V |
Pending |
453 |
Bifidobacterium breve M-16V |
Pending |
452 |
Enzyme modified steviol glycosides |
Pending |
451 |
Calcium ascorbate/calcium threonate |
Pending |
450 |
Chlorella protothecoides S106 flour with 40-70% lipid |
Pending |
449 |
Medium chain triglycerides |
Pending |
448 |
Enzyme modified steviol glycosides |
Pending |
447 |
Potato protein isolates |
Pending |
446 |
Red grape pomace extract |
Pending |
445 |
Bifidobacterium animalis subsp. lactis strains HN019, Bi-07, Bl-04 and B420 |
Pending |
444 |
Milk protein concentrate and milk protein isolate |
Pending |
443 |
Shrimp-derived chitosan |
Pending |
442 |
Volatile oil of mustard (white) |
Pending |
441 |
Sodium ferrous citrate |
Pending |
440 |
Lactobacillus reuteri NCIMB 30242 |
Pending |
439 |
Iron complex of tartaric acid |
At notifier's request, FDA ceased to evaluate the notice |
438 |
Plant stanol esters |
FDA has no questions |
437 |
Beta-glucans from oat bran |
FDA has no questions |
436 |
Enzyme-modified dextrins |
FDA has no questions |
435 |
Mixture of six bacterial monophages specific to Salmonella |
Pending |
434 |
Dried aqueous extract derived from white kidney bean (Phaseolus vulgaris) |
At notifier's request, FDA ceased to evaluate the notice |
433 |
Poloxamer fatty acid esters |
At notifier's request, FDA ceased to evaluate the notice |
432 |
Lutein diacetate |
FDA has no questions; some uses may require a color additive listing |
431 |
Colostral whey protein concentrate |
At notifier's request, FDA ceased to evaluate the notice |
430 |
Sugar beet fiber |
Pending |
429 |
Lactobacillus casei strain Shirota |
FDA has no questions |
428 |
Asparaginase enzyme preparation from genetically modified Aspergillus niger |
FDA has no questions |
427 |
Corn hull fiber |
FDA has no questions |
426 |
Rice hull fiber |
At notifier's request, FDA ceased to evaluate the notice |
425 |
Canola oil (low erucic acid rapeseed oil) |
FDA has no questions |
424 |
C-c-phycocyanin-enriched water extract of the cyanobacterium Arthrospira maxima or Arthrospira platensis, (also known as Spirulina maxima or Spirulina platensis) |
FDA has no questions; some uses may require a color additive listing |
423 |
Cow's milk-derived lactoferrin |
At notifier's request, FDA ceased to evaluate the notice |
422 |
Modified baker's yeast Saccharomyces cerevisiae |
FDA has no questions |
421 |
Sucrose fatty acid esters |
FDA has no questions |
420 |
Calcium acid pyrophosphate |
FDA has no questions |
419 |
L-alpha-glycerylphosphorylcholine |
FDA has no questions |
418 |
Rebaudioside A purified from the leaves of Stevia rebaudiana (Bertoni) Bertoni (rebaudioside A) |
FDA has no questions |
417 |
Dried biomass of Arthrospira platensis also known as Spirulina platensis (spirulina) |
FDA has no questions |
416 |
Lutein diacetate |
At notifier's request, FDA ceased to evaluate the notice |
415 |
Heat-killed Propionibacterium freudenreichii ET-3 culture (powder) |
FDA has no questions |
414 |
L-lysine monohydrochloride |
FDA has no questions |
413 |
Beta glucans derived from Ganoderma lucidum mycelium |
FDA has no questions |
412 |
Chitin-glucan from Aspergillus niger |
FDA has no questions |
411 |
Egg yolk-derived phospholipids |
FDA has no questions |
410 |
Lactobacillus reuteri strain DSM 17938 |
FDA has no questions |
409 |
Lactobacillus reuteri strain NCIMB 30242 |
At notifier's request, FDA ceased to evaluate the notice |
408 |
Sulfuric acid and sodium sulfate |
FDA has no questions |
407 |
Polysaccharide complex of konjac glucomannan (konjac), sodium alginate, and xanthan gum (polysaccharide complex KAX) |
FDA has no questions |
406 |
1,4-α-glucan branching enzyme preparation from Bacillus subtilis strain 168 expressing the glucan branching enzyme gene from Aquifex aeolicus strain VF5 |
FDA has no questions |
405 |
1,4-α-glucan branching enzyme preparation from Geobacillus stearothermophilus strain TRBE14 |
FDA has no questions |
404 |
Cyclic dextrin, highly branched |
FDA has no questions |
403 |
Carnallite sea salt (magnesium chloride, potassium chloride, salt) |
FDA has no questions |
402 |
Peroxidase enzyme preparation derived from a genetically modified strain of Aspergillus niger |
FDA has no questions |
401 |
Erythritol |
FDA has no questions |
400 |
D-psicose |
FDA has no questions |
399 |
Preparation of Bacillus coagulans strain GBI-30, 6086 spores |
FDA has no questions |
398 |
Vegetable oil and tall oil derived phytosterol and phytosterol ester formulations |
FDA has no questions |
397 |
Chitosan from Aspergillus niger |
FDA has no questions |
396 |
Chlorella vulgaris strain Beij |
At notifier's request, FDA ceased to evaluate the notice |
395 |
Steviol glycosides with rebaudioside A and stevioside as the principal components |
FDA has no questions |
394 |
Dried biomass of Arthrospira platensis, also known as Spirulina platensis (Spirulina) |
FDA has no questions |
393 |
Rebaudioside A purified from the leaves of Stevia rebaudiana (Bertoni) Bertoni (rebaudioside A) |
FDA has no questions |
392 |
Oligofructose |
FDA has no questions |
391 |
Spirulina (Anthrospira platensis) |
At notifier's request, FDA ceased to evaluate the notice |
390 |
Suspended lutein |
FDA has no questions |
389 |
Steviol glycosides with stevioside as the principal component |
FDA has no questions |
388 |
Rebaudioside A purified from the leaves of Stevia rebaudiana (Bertoni) Bertoni (rebaudioside A) |
FDA has no questions |
387 |
Plant-derived esterified and non-esterified sterols and stanols (phytosterols) |
FDA has no questions |
386 |
Canola protein isolate and hydrolyzed canola protein isolate |
FDA has no questions |
385 |
Lutein |
FDA has no questions |
384 |
Algal oil derived from Chlorella protothecoides strain S106 (Cp algal oil) |
FDA has no questions |
383 |
Magnesium dihydrogenpyrophosphate (MDPP) |
FDA has no questions |
382 |
Erythritol |
FDA has no questions |
381 |
Phytic acid |
FDA has no questions |
380 |
Rebaudioside A purified from the leaves of Stevia rebaudiana (Bertoni) Bertoni (rebaudioside A) |
FDA has no questions |
379 |
Tuna oil |
FDA has no questions |
378 |
Cultured [dairy sources, sugars, wheat, malt, and fruit- and vegetable-based sources] fermented by [Streptococcus thermophilus, Bacillus coagulans, Lactobacillus acidophilus, Lactobacillus paracasei subsp. paracasei, Lactobacillus plantarum, Lactobacillus sakei, Lactobacillus bulgaricus and Proprionibacterium freudenreichii subsp. shermanii or mixtures of these strains] |
FDA has no questions |
377 |
Bifidobacterium animalis subsp. lactis strain Bf-6 |
FDA has no questions |
376 |
Milk mineral concentrate |
FDA has no questions |
375 |
Enzyme modified steviol glycosides |
FDA has no questions |
374 |
Maleated isoprenyl polymer with methoxy-polyethylene glycol (MIP-MPEG) |
FDA has no questions |
373 |
Rice bran fiber |
FDA has no questions |
372 |
Glucoamylase enzyme preparation from Trichoderma reesei expressing the glucoamylase gene from T. reesei (glucoamylase enzyme preparation) |
FDA has no questions |
371 |
Krill oil |
FDA has no questions |
370 |
Xylooligosaccharide |
At notifier's request, FDA ceased to evaluate the notice |
369 |
Rebaudioside A purified from the leaves of Stevia rebaudiana (Bertoni) Bertoni  |
FDA has no questions |
368 |
Corn hull fiber |
At notifier's request, FDA ceased to evaluate the notice |
367 |
Purified steviol glycosides with rebaudioside A and stevioside as the principal components |
FDA has no questions |
366 |
Oat hull fiber |
At notifier's request, FDA ceased to evaluate the notice |
365 |
Rebaudioside A purified from the leaves of Stevia rebaudiana (Bertoni) Bertoni (rebaudioside A) Â |
FDA has no questions |
364 |
Bacteriophages LAND12, OLB1, TSRW1, DSMP1, DP1 |
At notifier's request, FDA ceased to evaluate the notice |
363 |
Calcium disodium ethylenediaminetetraacetic acid (EDTA) and disodium EDTA |
FDA has no questions |
362 |
Levocarnitine |
At notifier's request, FDA ceased to evaluate the notice |
361 |
1,4-α-D-glucan branching enzyme preparation |
At notifier's request, FDA ceased to evaluate the notice |
360 |
Hydrolyzed sardine protein |
FDA has no questions |
359 |
Siraitia grosvenorii Swingle (Luo Han Guo) fruit extracts (SGFE) |
FDA has no questions |
358 |
Cyclic dextrin, highly branched |
At notifier's request, FDA ceased to evaluate the notice |
357 |
Lactobacillus acidophilus NCFM |
FDA has no questions |
356 |
Haematococcus pluvialis extract containing astaxanthin esters |
At notifier's request, FDA ceased to evaluate the notice |
355 |
Eicosapentaenoic acid (EPA)-rich triglyceride oil from Yarrowia lipolytica |
FDA has no questions |
354 |
Rebaudioside A purified from the leaves of Stevia rebaudiana (Bertoni) Bertoni (rebaudioside A) |
FDA has no questions |
353 |
High-selenium yeast |
FDA has no questions |
352 |
D-Tagatose |
FDA has no questions |
351 |
Dunaliella bardawil |
FDA has no questions |
350 |
Saccharomyces cerevisiae strain P1Y0, a variant of S. cerevisiae parent strain UCD2034 |
FDA has no questions |
349 |
Purified steviol glycosides with rebaudioside A and stevioside as the principal components |
FDA has no questions |
348 |
Stevioside purified from the leaves of Stevia rebaudiana (Bertoni) Bertoni (stevioside) |
FDA has no questions |
347 |
Caffeine |
At notifier's request, FDA ceased to evaluate the notice |
346 |
Freeze-dried fruit gac powder |
At notifier's request, FDA ceased to evaluate the notice |
345 |
Carboxypeptidase enzyme preparation from modified Aspergillus niger |
FDA has no questions |
344 |
Barley fiber |
FDA has no questions |
343 |
Wheat bran extract composed primarily of xylo- and arabinoxylo-oligosaccharides |
FDA has no questions |
342 |
Oat hull fiber |
FDA has no questions |
341 |
Quercetin |
FDA has no questions; some uses may require a color additive listing |
340 |
Theobromine |
At notifier's request, FDA ceased to evaluate the notice |
339 |
Polyglutamic acid |
FDA has no questions |
338 |
L-theanine extracted from tea leaves (Camellia sinensis) |
FDA has no questions |
337 |
Enzyme modified steviol glycosides preparation (EMSGP) |
FDA has no questions |
336 |
ε-Polylysine (polylysine) |
FDA has no questions |
335 |
Pine tree phytosterol esters |
FDA has no questions |
334 |
Galacto-oligosaccharides |
FDA has no questions |
333 |
Acid fungal protease enzyme preparation from Trichoderma reesei expressing the gene encoding acid fungal protease from T. reesei |
FDA has no questions |
332 |
Oil from the seeds of the Korean pine (Pinus koraiensis) (Korean-pine nut oil) |
FDA has no questions |
331 |
Algal oil (Chlorella protothecoides) |
At notifier's request, FDA ceased to evaluate the notice |
330 |
Algal flour (Chlorella protothecoides) |
At notifier's request, FDA ceased to evaluate the notice |
329 |
Rebaudioside A purified from the leaves of Stevia rebaudiana (Bertoni) Bertoni |
FDA has no questions |
328 |
Polysaccharide complex of konjac glucomannan (konjac), sodium alginate, and xanthan gum (polysaccharide complex KAX) |
Notice does not provide a basis for a GRAS determination. |
327 |
Cruciferin-rich canola/rapeseed protein isolate and napin-rich canola/rapeseed protein isolate |
FDA has no questions |
326 |
Arachidonic acid rich oil from M. alpina strain I49-N18 |
FDA has no questions |
325 |
Olestra |
FDA has no questions |
324 |
Heat-killed Lactobacillus plantarum |
At notifier's request, FDA ceased to evaluate the notice |
323 |
Purified steviol glycosides with rebaudioside A and stevioside as the principal components |
FDA has no questions |
322 |
Aqueous extract of Emblica officinalis |
At notifier's request, FDA ceased to evaluate the notice |
321 |
Synthetic amorphous silica |
FDA has no questions |
320 |
Palm oil-derived carotenoids with β-carotene, α-carotene, γ-carotene, and lycopene |
FDA has no questions; some uses may require a color additive listing |
319 |
Micro-algal oil Ulkenia sp. SAM2179 |
FDA has no questions; some uses may require a color additive listing |
318 |
Rebaudioside A purified from the leaves of Stevia rebaudiana (Bertoni) Bertoni |
FDA has no questions |
317 |
L-arginine |
FDA has no questions |
316 |
Sodium potassium hexametaphosphate |
FDA has no questions |
315 |
Transglucosidase enzyme preparation from Trichoderma reesei expressing the gene encoding transglucosidase from Aspergillus niger |
FDA has no questions |
314 |
Pork protein |
FDA has no questions |
313 |
Beef protein |
FDA has no questions |
312 |
Synthetic dihydrocapsiate |
FDA has no questions |
311 |
Krill-based phosphatidylserine |
FDA has no questions; some uses may require a color additive listing |
310 |
Potato fiber |
FDA has no questions |
309 |
Beta-glucan derived from Aureobasidium pullulans |
FDA has no questions |
308 |
L-leucine |
FDA has no questions |
307 |
Palm oil-derived tocols with tocotrienols and α-tocopherol as the principal components |
FDA has no questions; some uses may require a color additive listing |
306 |
Soybean oil with reduced palmitic and linolenic acids and increased oleic acid |
FDA has no questions |
305 |
Carnobacterium maltaromaticum strain CB1 (viable and heat-treated) |
FDA has no questions |
304 |
Purified steviol glycosides with rebaudioside A and stevioside as the principal components |
FDA has no questions |
303 |
Rebaudioside A purified from the leaves of Stevia rebaudiana (Bertoni) Bertoni |
FDA has no questions |
302 |
1,3-propanediol |
FDA has no questions |
301 |
Siraitia grosvenorii Swingle (Luo Han Guo) fruit extract (SGFE) |
FDA has no questions |
300 |
Trisodium diphosphate |
FDA has no questions |
299 |
Lycopene from Escherichia coli expressing lycopene biosynthetic enzymes |
At notifier's request, FDA ceased to evaluate the notice |
298 |
Silicon dioxide |
At notifier's request, FDA ceased to evaluate the notice |
297 |
Erythritol fatty acid esters |
FDA has no questions |
296 |
Lipase enzyme preparation from a genetically modified strain of Aspergillus niger |
FDA has no questions |
295 |
Aqueous extract of Emblica officinalis |
At notifier's request, FDA ceased to evaluate the notice |
294 |
Haematococcus pluvialis extract containing astaxanthin esters |
FDA has no questions; some uses may require a color additive listing |
293 |
Glutathione |
FDA has no questions |
292 |
Cellulase enzyme preparation derived from a genetically modified strain of Myceliophthora thermophila |
FDA has no questions |
291 |
Crystalline lutein |
FDA has no questions |
290 |
L-arginine |
FDA has no questions |
289 |
Colicin E1 purified from Escherichia coli |
At notifier's request, FDA ceased to evaluate the notice |
288 |
Lactobacillus rhamnosus strain HN001 |
FDA has no questions |
287 |
Purified steviol glycosides with rebaudioside A and stevioside as the principal components |
FDA has no questions |
286 |
Galacto-oligosaccharides |
FDA has no questions |
285 |
Galacto-oligosaccharides |
FDA has no questions |
284 |
Bakers yeast mannoprotein |
FDA has no questions |
283 |
Stearidonic acid soybean oil |
FDA has no questions |
282 |
Rebaudioside A purified from the leaves of Stevia rebaudiana (Bertoni) Bertoni |
FDA has no questions |
281 |
Lactobacillus rhamnosus strain HN001 produced in a milk-based medium |
FDA has no questions |
280 |
Whole and milled flaxseed |
FDA has no questions |
279 |
Phosphatidylserine derived from fish |
FDA has no questions |
278 |
Rebaudioside A purified from the leaves of Stevia rebaudiana (Bertoni) Bertoni |
FDA has no questions |
277 |
Maltotetraohydrolase enzyme preparation from Bacillus licheniformis expressing a modified maltotetraohydrolase gene from Pseudomonas stutzeri |
FDA has no questions |
276 |
Dunaliella bardawil alga |
At notifier's request, FDA ceased to evaluate the notice |
275 |
Purified steviol glycosides with rebaudioside A as the principal component |
FDA has no questions |
274 |
Branching glycosyltransferase enzyme preparation from Bacillus subtilis expressing a branching glycosyltransferase gene from Rhodothermus obamensis |
FDA has no questions |
273 |
Baobab (Adansonia digitata) dried fruit pulp |
FDA has no questions |
272 |
Triple salt of magnesium, ammonium, and potassium chloride, hexahydrate |
FDA has no questions |
271 |
Ferrous ammonium phosphate |
FDA has no questions |
270 |
Polyglycerol polyricinoleic acid |
FDA has no questions |
269 |
Polyglycerol fatty acid esters with a degree of polymerization of 11 to 40 for the polyglycerol backbone |
FDA has no questions |
268 |
Bifidobacterium longum strain BB536 |
FDA has no questions |
267 |
Protein glutaminase enzyme preparation derived from Chryseobacterium proteolyticum |
FDA has no questions |
266 |
Polyglycerol polyricinoleate |
FDA has no questions |
265 |
Glycerophospholipid cholesterol acyltransferase (GCAT) enzyme preparation from Bacillus licheniformis expressing a modified GCAT gene from Aeromonas salmonicida subsp. salmonicida |
FDA has no questions (additional correspondence available) |
264 |
Sweet lupin flour |
At notifier's request, FDA ceased to evaluate the notice |
263 |
Sweet lupin fiber |
At notifier's request, FDA ceased to evaluate the notice |
262 |
Sweet lupin protein |
At notifier's request, FDA ceased to evaluate the notice |
261 |
Oat hull fiber |
FDA has no questions |
260 |
High-selenium yeast |
FDA has no questions |
259 |
Catechins from green tea extract |
At notifier's request, FDA ceased to evaluate the notice |
258 |
Sucromalt |
FDA has no questions |
257 |
gamma-Amino butyric acid |
At notifier's request, FDA ceased to evaluate the notice |
256 |
High linolenic acid flaxseed oil |
FDA has no questions |
255 |
Bovine globulin |
FDA has no questions |
254 |
Lactobacillus reuteri strain DSM 17938 |
FDA has no questions |
253 |
Rebaudioside A purified from Stevia rebaudiana (Bertoni) Bertoni |
FDA has no questions |
252 |
Rebaudioside A purified from Stevia rebaudiana (Bertoni) Bertoni |
FDA has no questions |
251 |
Carbon monoxide |
FDA has no questions |
250 |
Plant sterols and stanols from pine trees |
FDA has no questions |
249 |
Synthetic dihydrocapsiate |
FDA has no questions |
248 |
Sucrose fatty acid esters (i.e., sucrose monoesters of lauric acid, palmitic acid, and stearic acid) manufactured by reaction of sucrose with vinyl esters of lauric, palmitic, and stearic acids |
FDA has no questions |
247 |
Modified gum acacia |
FDA has no questions |
246 |
Isomalto-oligosaccharide mixture |
FDA has no questions |
245 |
Menaquinone-7 |
At notifier's request, FDA ceased to evaluate the notice |
244 |
Glutathione |
At notifier's request, FDA ceased to evaluate the notice |
243 |
D-Ribose |
FDA has no questions |
242 |
Krill oil |
FDA has no questions; some uses may require a color additive listing |
241 |
High-selenium yeast |
At notifier's request, FDA ceased to evaluate the notice |
240 |
Corn, cane, or beet sugar cultured with Lactobacillus paracasei subsp. paracasei, Bacillus coagulans LA-1, or Propionibacterium freudenreichii subsp. shermanii, or mixtures of these microorganisms |
FDA has no questions |
239 |
Bakers yeast beta-glucan |
FDA has no questions |
238 |
Lipase enzyme preparation derived from Hansenula polymorpha expressing a gene encoding a lipase from Fusarium heterosporum |
FDA has no questions |
237 |
Alkyl polyglycosides |
FDA has no questions |
236 |
Galacto-oligosaccharides |
FDA has no questions |
235 |
Human lactoferrin purified from rice |
At notifier's request, FDA ceased to evaluate the notice |
234 |
Bovine globulin |
At notifier's request, FDA ceased to evaluate the notice |
233 |
Combination of galacto-oligosaccharides and polydextrose |
FDA has no questions |
232 |
Conjugated linoleic acid isomers |
FDA has no questions (additional correspondence available) |
231 |
Lactobacillus casei subsp. rhamnosus strain GG |
FDA has no questions |
230 |
Chymosin enzyme preparation from Trichoderma reesei expressing the bovine prochymosin B gene |
FDA has no questions |
229 |
Methylsulfonylmethane |
FDA has no questions |
228 |
Sodium nitrite embedded on one side of a food packaging film at a maximum level of 113 milligrams per square meter |
FDA has no questions |
227 |
Olestra |
FDA has no questions |
226 |
Lecithin derived from krill |
FDA has no questions |
225 |
Catechins from green tea extract |
At notifier's request, FDA ceased to evaluate the notice |
224 |
trans-Resveratrol |
At notifier's request, FDA ceased to evaluate the notice |
223 |
Phosphatidylserine |
FDA has no questions |
222 |
Citric acid esters of mono- and diglycerides |
FDA has no questions |
221 |
Suspended lutein |
FDA has no questions; some uses may require a color additive listing |
220 |
alpha-Glycosyl isoquercitrin |
FDA has no questions |
219 |
Ammonium phosphatide |
FDA has no questions |
218 |
Bacteriophage P100 preparation from Listeria innocua |
FDA has no questions |
217 |
Tailored triglycerides containing approximately 12 percent medium-chain fatty acids |
FDA has no questions |
216 |
Lipase enzyme preparation from Rhizopus oryzae |
FDA has no questions |
215 |
Actinidia arguta extract |
FDA has no questions |
214 |
Asparaginase enzyme preparation from Aspergillus niger expressing the asparaginase gene from A. niger |
FDA has no questions |
213 |
Hydroxypropyl methylcellulose - expanded substitution pattern (HPMC-ESP) |
FDA has no questions |
212 |
Phospholipase A2 enzyme preparation from Streptomyces violaceruber expressing a gene encoding phospholipase A2 from the same species |
FDA has no questions |
211 |
Xanthan gum (lower pyruvate levels) |
FDA has no questions |
210 |
Water soluble tomato concentrate |
FDA has no questions; some uses may require a color additive listing |
209 |
L-theanine |
FDA has no questions |
208 |
Erythritol |
FDA has no questions |
207 |
Barley fiber |
FDA has no questions |
206 |
Phytosterol esters and diglycerides resulting from transesterification of vegetable oils/fats with phytosterols |
FDA has no questions |
205 |
Pullulanase enzyme preparation from Bacillus subtilis expressing the pullulanase gene from B. acidopullulyticus |
FDA has no questions |
204 |
Phospholipase C enzyme preparation from Pichia pastoris expressing a heterologous phospholipase C gene |
FDA has no questions |
203 |
Erythritol fatty acid esters |
At notifier's request, FDA ceased to evaluate the notice |
202 |
Polyoxyethanyl-alpha-tocopheryl sebacate (PTS) |
FDA has no questions |
201 |
Asparaginase enzyme preparation from Aspergillus oryzae expressing the asparaginase gene from A. oryzae |
FDA has no questions |
200 |
Tailored triglycerides enriched in omega-3 fatty acids from fish oil |
FDA has no questions |
199 |
Concentrated hydrolyzed milk protein |
FDA has no questions (additional correspondence available) |
198 |
Bacteriophage P100 preparation from Listeria innocua |
FDA has no questions |
197 |
Phosphatidylserine |
FDA has no questions |
196 |
Bovine milk basic protein fraction |
FDA has no questions |
195 |
Mixed beta-Glucanase and xylanase enzyme preparation from Humicola insolens |
FDA has no questions |
194 |
Carbon monoxide |
FDA has no questions |
193 |
Fish oil (predominantly sardine and anchovy); tuna oil |
FDA has no questions |
192 |
High 2-palmitic vegetable oil |
FDA has no questions |
191 |
Human lysozyme purified from rice |
At notifier's request, FDA ceased to evaluate the notice |
190 |
Hydroxypropyl methylcellulose |
At notifier's request, FDA ceased to evaluate the notice |
189 |
Lactoferrin (human) purified from bovine milk |
At notifier's request, FDA ceased to evaluate the notice |
188 |
Carbon monoxide |
At notifier's request, FDA ceased to evaluate the notice |
187 |
L(+) Tartaric acid (alternative method of manufacture) |
FDA has no questions |
186 |
Soy lecithin enzymatically modified to have increased phosphatidylserine |
FDA has no questions |
185 |
Concentrated tomato lycopene extract |
FDA has no questions; some uses may require a color additive listing |
184 |
Isomaltulose |
FDA has no questions |
183 |
Phospholipase A2 enzyme preparation from Aspergillus niger expressing a gene encoding a porcine phospholipase A2 |
FDA has no questions |
182 |
Hydrolyzed wheat gluten isolate; pea protein isolate |
FDA has no questions |
181 |
Phytosterols |
FDA has no questions |
180 |
Allyl isothiocyanate |
FDA has no questions |
179 |
Polyglycerol polyricinoleic acid |
FDA has no questions |
178 |
Sodium iron EDTA |
FDA has no questions |
177 |
Plant sterol esters |
FDA has no questions |
176 |
Plant sterols and plant sterol esters from vegetable oils or sterols/stanols from tall oil |
FDA has no questions |
175 |
Saccharomyces cerevisiae strain ECMo01 with enhanced expression of urea amidolyase |
FDA has no questions |
174 |
Lysozyme (human) enzyme preparation from rice |
At notifier's request, FDA ceased to evaluate the notice. |
173 |
Lycopene from Blakeslea trispora |
FDA has no questions; some uses may require a color additive listing |
172 |
Isomalto-oligosaccharide |
At notifier's request, FDA ceased to evaluate the notice. |
171 |
Lactobacillus acidophilus, Lactobacillus lactis, and Pediococcus acidilactici |
FDA has no questions (additional correspondence available) |
170 |
Shrimp-derived chitosan |
At notifier's request, FDA ceased to evaluate the notice. |
169 |
Bovine globulin |
At notifier's request, FDA ceased to evaluate the notice. |
168 |
Poultry protein |
FDA has no questions |
167 |
Carbon monoxide |
FDA has no questions |
166 |
Carbon monoxide |
At notifier's request, FDA ceased to evaluate the notice. |
165 |
Quillaia extract type 1 |
FDA has no questions |
164 |
Lauramide arginine ethyl ester |
FDA has no questions (additional correspondence available) |
163 |
Tomato pulp powder |
FDA has no questions (additional correspondence available) |
162 |
Lactoferrin (human) purified from rice |
At notifier's request, FDA ceased to evaluate the notice. |
161 |
Chlorine dioxide, generated using sodium chlorite in calcined or sulfated kaolin clay |
FDA has no questions |
160 |
Micro-algal oil (Ulkenia sp.) |
At notifier's request, FDA ceased to evaluate the notice. |
159 |
Carnobacterium maltaromaticum strain CB1 |
FDA has no questions |
158 |
Lipase preparation from Aspergillus niger expressing a gene encoding a lipase from Candida antartica |
FDA has no questions |
157 |
Calcium propionate (alternative method of manufacture) |
FDA has no questions |
156 |
Tomato lycopene extract 6 percent, tomato lycopene extract 1.5 percent, and crystallized tomato lycopene extract |
FDA has no questions (additional correspondence available); some uses may require a color additive listing |
155 |
alpha-Cyclodextrin |
FDA has no questions |
154 |
Dried orange pulp |
FDA has no questions |
153 |
Conjugated linoleic acid |
At notifier's request, FDA ceased to evaluate the notice. |
152 |
Sodium iron EDTA |
FDA has no questions |
151 |
Ethanol (ethyl alcohol) |
FDA has no questions |
150 |
Glucosamine hydrochloride prepared from chitin obtained from Aspergillus niger |
At notifier's request, FDA ceased to evaluate the notice. |
149 |
Beta-glucanase enzyme preparation from Trichoderma harzianum |
FDA has no questions |
148 |
Vegetable oil conjugated linoleic acid preparation |
At notifier's request, FDA ceased to evaluate the notice. |
147 |
Extracted "seafood species" protein |
FDA has no questions (additional correspondence available) |
146 |
Salmon oil |
FDA has no questions |
145 |
Phospholipase A2 enzyme preparation from Streptomyces violaceoruber |
FDA has no questions |
144 |
Adenosine 5'-monophosphoric acid and its monosodium and disodium salts |
FDA has no questions |
143 |
Carbon monoxide |
FDA has no questions |
142 |
Phospholipase enzyme preparation from Aspergillus oryzae expressing the gene encoding a phospholipase A1 from Fusarium venenatum |
FDA has no questions |
141 |
Polyvinyl alcohol |
FDA has no questions |
140 |
Crystalline lutein |
FDA has no questions; some uses may require a color additive listing |
139 |
Cassia gum |
At notifier's request, FDA ceased to evaluate the notice. |
138 |
Fish oil |
FDA has no questions |
137 |
Algal oil (Schizochytrium sp.) |
FDA has no questions |
136 |
Calcium gluconate |
FDA has no questions |
135 |
ε-Polylysine |
FDA has no questions |
134 |
Soy protein hydrolyzate with enzyme-modified lecithin |
FDA has no questions |
133 |
Volatile oil of mustard |
FDA has no questions |
132 |
Lactase enzyme preparation from Aspergillus niger |
FDA has no questions |
131 |
High 2-palmitic vegetable oil |
FDA has no questions (additional correspondence available) |
130 |
Bovine milk-derived lactoferrin |
FDA has no questions (additional correspondence available) |
129 |
Sucrose fatty acid esters |
FDA has no questions |
128 |
Skim milk or dextrose cultured with Propionibacterium freudenreichii subsp. shermanii |
FDA has no questions |
127 |
Spirulina, the dried biomass of Arthrospira platensis |
FDA has no questions; some uses may require a color additive listing |
126 |
Alpha-amylase enzyme preparation from Pseudomonas fluorescens Biovar I expressing a gene encoding a hybrid alpha-amylase derived from three microorganisms within the order Thermococcales |
FDA has no questions |
125 |
Grape seed extract and grape pomace extract |
FDA has no questions; some uses may require a color additive listing |
124 |
Grape seed extract |
FDA has no questions |
123 |
Laminaria japonica broth and extract powder |
FDA has no questions |
122 |
Laccase enzyme preparation produced by Aspergillus oryzae expressing the gene encoding a laccase from Myceliophthora thermophila |
FDA has no questions |
121 |
Xanthan gum |
FDA has no questions |
120 |
Saccharomyces cerevisiae strain ML01 carrying a gene encoding the malolactic enzyme from Oenococcus oeni and a gene encoding malate permease from Schizosaccharomyces pombe |
FDA has no questions |
119 |
Synthetic lycopene |
FDA has no questions; some uses may require a color additive listing |
118 |
Inulin |
FDA has no questions (additional correspondence available) |
117 |
Ice structuring protein preparation |
FDA has no questions |
116 |
Carrot fiber |
FDA has no questions |
115 |
Diacylglycerol oil |
FDA has no questions |
114 |
Pectate lyase enzyme preparation from Bacillus subtilis |
FDA has no questions |
113 |
Lipase enzyme preparation from Aspergillus oryzae |
FDA has no questions |
112 |
Phytosterols |
FDA has no questions |
111 |
Lipase enzyme preparation from Aspergillus niger |
FDA has no questions |
110 |
Lutein esters |
FDA has no questions; some uses may require a color additive listing |
109 |
Tuna oil |
FDA has no questions |
108 |
Glycerol ester of gum rosin |
Notice does not provide a basis for a GRAS determination |
107 |
Polydextrose |
At notifier's request, FDA ceased to evaluate the notice |
106 |
Glucose oxidase enzyme preparation from Aspergillus oryzae carrying a gene encoding a glucose oxidase from Aspergillus niger |
FDA has no questions |
105 |
Fish oil concentrate |
FDA has no questions |
104 |
Sucrose acetate isobutyrate |
FDA has no questions |
103 |
Lipase enzyme preparation from Aspergillus oryzae carrying a gene constructed from a modified Thermomyces lanuginosus lipase gene and a portion of the Fusarium oxysporum lipase gene |
FDA has no questions |
102 |
Small planktivorous pelagic fish body oil |
FDA has no questions |
101 |
Spirulina |
At notifier's request, FDA ceased to evaluate the notice. |
100 |
D-Ribose |
Notice does not provide a basis for a GRAS determination |
99 |
Pullulan |
FDA has no questions |
98 |
Small planktivorous pelagic fish body oil |
At notifier's request, FDA ceased to evaluate the notice. |
97 |
Tuna oil |
At notifier's request, FDA ceased to evaluate the notice. |
96 |
Silk protein food powder |
Notice does not provide a basis for a GRAS determination |
95 |
Transglutaminase from Streptoverticillium mobaraense |
FDA has no questions |
94 |
Docosahexaenoic acid-rich oil from tuna (DHA-rich tuna oil) and arachidonic acid-rich oil from Mortierella alpina (AA-rich fungal oil) |
FDA has no questions |
93 |
Grape seed extract and grape skin extract |
Notice does not provide a basis for a GRAS determination. |
92 |
Sucrose fatty acid esters |
Notice does not provide a basis for a GRAS determination. |
91 |
Mycoprotein |
FDA has no questions |
90 |
Carbohydrase enzyme preparation from Aspergillus oryzae, protease enzyme preparation from Aspergillus oryzae, and carbohydrase enzyme preparation from Rhizopus oryzae |
FDA has no questions (additional correspondence available) |
89 |
Five enzyme preparations from Aspergillus niger: Carbohydrase enzyme preparation, catalase enzyme preparation, glucose oxidase enzyme preparation, pectinase enzyme preparation, and protease enzyme preparation |
FDA has no questions (additional correspondence available) |
88 |
Invertase enzyme preparation from Saccharomyces cerevisiae and lactase enzyme preparation from Kluyveromyces marxianus |
FDA has no questions |
87 |
Composite filtration media (diatomaceous earth and perlite) |
FDA has no questions |
86 |
Coagulated potato protein, hydrolyzed potato protein, or clarified hydrolyzed potato protein |
FDA has no questions |
85 |
Isoamylase from Pseudomonas amyloderamosa |
FDA has no questions |
84 |
Arabinogalactan from Eastern Larch (Larix laricina) |
FDA has no questions |
83 |
Carbon monoxide |
FDA has no questions |
82 |
1,1,1,2-Tetrafluoroethane (HFC-134a) |
FDA has no questions |
81 |
Lipase from Candida rugosa |
FDA has no questions |
80 |
ARASCO (arachidonic acid-rich single-cell oil) |
FDA has no questions |
79 |
Alpha-amylase derived from Bacillus licheniformis carrying a gene encoding a modified alpha-amylase from Bacillus licheniformis |
FDA has no questions |
78 |
D-Tagatose |
FDA has no questions |
77 |
Milk-derived lactoferrin |
FDA has no questions |
76 |
Erythritol |
FDA has no questions |
75 |
Lipase derived from Aspergillus oryzae carrying a gene encoding lipase from Fusarium oxysporum |
FDA has no questions |
74 |
Beta-cyclodextrin |
FDA has no questions |
73 |
Shrimp-derived chitosan |
At notifier's request, FDA ceased to evaluate the notice |
72 |
Pullulanase derived from Bacillus licheniformis carrying a gene encoding pullulanase from B. deramificans |
FDA has no questions |
71 |
White mineral oil, USP (viscosity ISO 100 ) |
FDA has no questions |
70 |
Stearyl alcohol |
FDA has no questions |
69 |
Behenic acid |
FDA has no questions |
68 |
Lipase from Penicillium camembertii |
FDA has no questions |
67 |
Milk-derived lactoferrin |
FDA has no questions |
66 |
Milk thistle extract |
Notice does not provide a basis for a GRAS determination |
65 |
Nisin |
FDA has no questions |
64 |
Egg white lysozyme |
FDA has no questions |
63 |
Hops beta acids |
FDA has no questions |
62 |
Chlorine dioxide generated from particles (<30μm) composed of sodium polyphosphate, magnesium sulfate, sodium silicate and sodium chlorite that are incorporated into low density polyethylene (LDPE) food-packaging films, at levels not exceeding 17.5 micrograms chlorite/in2 of finished package film |
FDA has no questions (additional correspondence available) |
61 |
Plant sterols/Plant sterol esters |
FDA has no questions |
60 |
Potassium bisulfate |
FDA has no questions |
59 |
Hydrogenated starch hydrolysate |
At notifier's request, FDA ceased to evaluate the notice |
58 |
Gum arabic |
At notifier's request, FDA ceased to evaluate the notice |
57 |
Argon gas |
FDA has no questions |
56 |
Diacylglycerol oil |
FDA has no questions |
55 |
Transglutaminase from Streptoverticillium mobaraense |
FDA has no questions |
54 |
Xylanase derived from Fusarium venenatum carrying a gene encoding xylanase from Thermomyces lanuginosus |
FDA has no questions |
53 |
Phytosterol esters |
FDA has no questions |
52 |
Whey mineral concentrate |
FDA has no questions |
51 |
Cassia gum from Cassia tora/obtusifolia |
At notifier's request, FDA ceased to evaluate the notice. |
50 |
Bohenin |
FDA has no questions |
49 |
Bifidobacterium lactis strain Bb12 and Streptococcus thermophilus strain Th4 |
FDA has no questions (additional correspondence available) |
48 |
Vegetable oil phytosterol esters |
FDA has no questions |
47 |
Arabinogalactan from Larix occidentalis |
FDA has no questions |
46 |
Gamma cyclodextrin |
FDA has no questions |
45 |
Trehalose |
FDA has no questions |
44 |
Fructooligosaccharide |
FDA has no questions (additional correspondence available) |
43 |
Lipase derived from Aspergillus oryzae carrying a gene encoding lipase from Thermomyces lanuginosus |
FDA has no questions (additional correspondence available) |
42 |
Milk-derived lactoferrin |
Notice does not provide a basis for a GRAS determination (additional correspondence available) |
41 |
DHASCO (docosahexaenoic acid-rich single-cell oil) and ARASCO (arachidonic acid-rich single-cell oil) |
FDA has no questions |
40 |
Mineral oil |
Notice does not provide a basis for a GRAS determination |
39 |
Tall oil phytosterols |
FDA has no questions (additional correspondence available) |
38 |
Cetylpyridinium chloride |
Notice does not provide a basis for a GRAS determination |
37 |
Whey protein isolate and dairy product solids |
FDA has no questions (additional correspondence available) |
36 |
Chromium picolinate; Ginkgo biloba leaf extract; and Ginseng extract |
At notifier's request, FDA ceased to evaluate the notice |
35 |
Hempseed oil |
Notice does not provide a basis for a GRAS determination |
34 |
Aspartic proteinase derived from Aspergillus oryzae carrying a gene encoding aspartic proteinase from Rhizomucor miehei |
FDA has no questions |
33 |
Low erucic acid oil derived from Brassica juncea |
FDA has no questions |
32 |
Pectin lyase derived from Trichoderma reesei carrying a gene encoding pectin lyase from Aspergillus niger |
FDA has no questions |
31 |
Cetylpyridinium chloride |
At notifier's request, FDA ceased to evaluate the notice. |
30 |
Crospovidone-cranberry juice extract |
Notice does not provide a basis for a GRAS determination (additional correspondence available) |
29 |
Transglutaminase from Streptoverticillium mobaraense |
FDA has no questions |
28 |
Seaweed-derived calcium |
FDA has no questions (additional correspondence available) |
27 |
Dextranase from Chaetomium gracile |
FDA has no questions |
26 |
Isolated wheat protein |
FDA has no questions |
25 |
Extract of Garcinia kola seed ("bitter cola") |
Notice does not provide a basis for a GRAS determination |
24 |
alpha-Amylase derived from Bacillus licheniformis carrying a gene encoding alpha-amylase from Bacillus stearothermophilus |
FDA has no questions |
23 |
Protein preparation from animal blood |
At notifier's request, FDA ceased to evaluate the notice |
22 |
alpha-Amylase derived from Bacillus licheniformis carrying a gene encoding a modified alpha-amylase derived from Bacillus lichenformis and Bacillus amyloliquefaciens |
FDA has no questions |
21 |
Pork collagen |
FDA has no questions |
20 |
Pullulanase derived from Bacillus subtilis carrying a gene encoding pullulanase from Bacillus naganoensis |
FDA has no questions |
19 |
Ferrous bisglycinate chelate |
FDA has no questions |
18 |
Mesquite (Prosopis spp.) wood alcoholic extract |
FDA has no questions |
17 |
Arabinogalactan |
At notifier's request, FDA ceased to evaluate the notice. |
16 |
Menhaden oil |
At notifier's request, FDA ceased to evaluate the notice |
15 |
Tasteless smoke |
FDA has no questions |
14 |
Hydrogen peroxide |
Notice does not provide a basis for a GRAS determination |
13 |
Botanicals: Chrysanthemum; Licorice; Jellywort AND Honeysuckle; Lophatherum; Mulberry leaf; Frangipani; Selfheal; Sophora flower bud |
FDA has no questions AND Notice does not provide a basis |
12 |
Mesquite wood alcoholic extract |
At notifier's request, FDA ceased to evaluate the notice. |
11 |
Calcium casein peptone-calcium phosphate |
FDA has no questions |
10 |
Exopeptidase derived from Aspergillus oryzae carrying a gene encoding a leucine aminopeptidase from Aspergillus sojae |
Notice does not provide a basis for a GRAS determination |
9 |
Polyglycerol polyricinoleic acid |
FDA has no questions |
8 |
Pectin esterase derived from Aspergillus oryzae carrying a gene encoding pectin esterase from Aspergillus aculeatus |
FDA has no questions |
7 |
ARASCO (arachidonic acid-rich single-cell oil) and DHASCO (docosahexaenoic acid-rich single-cell oil) as sources of the fatty acids ARA (arachidonic acid) and DHA (docosahexaenoic acid) |
Notice does not provide a basis for a GRAS determination. |
6 |
Dioctyl sodium sulfosuccinate |
FDA has no questions |
5 |
Tasteless smoke |
At notifier's request, FDA ceased to evaluate the notice. |
4 |
Transglutaminase from Streptoverticillium mobaraense |
FDA has no questions |
3 |
Sodium bisulfate |
FDA has no questions |
2 |
Solin oil (low linolenic acid flaxseed oil or low linolenic acid linseed oil) |
FDA has no questions |
1 |
Soy isoflavone extract |
At notifier's request, FDA ceased to evaluate the notice |